Abstract:Epigenetics has been known to mediate genetic risks and regulate gene expression in complex diseases. Due to substantial epigenetic variation, particularly DNA methylation, is tissue specific, sample accessibility has been one of the major road blockers in epigenetic research for human brain disorders. However, previous studies have shown that DNA methylation can also be significantly regulated by genetics and such effect is relatively consistent cross tissues. A better understanding of this genetic and epigenetic relationship can be very beneficial for the investigation of diseases pathology. In this work, we conducted a comprehensive analysis of genetic influence on DNA methylation across brain and peripheral tissues, characterized genetics and their target CpGs, and their functional relevance to psychiatric diseases. We performed a genome-wide methylation quantitative trait loci (meQTLs) analysis on postmortem brain prefrontal cortex, whole blood and saliva. Cis-acting SNP-methylation pairs (distance < 20k base pairs) were matched across tissues. The overlap of meQTLs and targeted CpG sites in different tissues were evaluated by a Fisher exact test. Cis-effect size among tissues was also compared. While focusing on cross tissue consistent SNP-methylation effects, enrichment tests were applied to explore the genomic distribution of targeted CpG sites, their annotation in functional pathways and diseases, and their enrichment in the CpG set with high brain-blood correspondence. In addition, we tested the enrichment of cross-tissue meQTLs in risk loci of five major psychiatric disorders reported by large-scale genome-wide association studies, and further explored their overlap with cross-tissue expression QTLs. Finally, we constructed cross-tissue consensus co-methylation networks for the meQTL targeted CpG sites. We found significant overlap of meQTLs and targeted CpGs cross tissue (34%-73%). MeQTLs in blood showed the strongest cis-effect followed by brain and saliva regardless of direction of effect. Cross-tissue meQTL targeted CpGs were highly distributed on CpG island shore regions (OR: odds ratio = 1.3, P = 2.8e-99) and had a much higher probability being blood brain correspondent than non-meQTL target CpGs (OR=6.6). Cross-tissue meQTLs showed significant enrichment in risk loci of five major psychiatric disorders (OR: odds ratio = [1.65 - 5.42]). In addition, these cross-tissue meQTLs also enriched significantly in cross-tissue eQTLs (OR = 16.21), where 351 SNPs were meQTl, eQTL, and carried significant schizophrenia risk, mainly from regions 6p21.1 – 6p24.3. Finally, we found more similar co-methylation network structure between brain and blood than brain and saliva, and identified one consensus module showing significant schizophrenia risk (Z= -4.54, p = 5.5e-6). Results show strong cross-tissue similarity of meQTLeffects, especially between brain and blood, and their significant enrichment in psychiatric disorders, supporting the surrogate role of peripheral tissues in studying pathology of genetic effect on brain disorders through methylation.

Altered DNA methylation associated with a translocation linked to major mental illness

DNA Methylation in Schizophrenia: Progress and Challenges

DNA Methylation Meta-Analysis Reveals Cellular Alterations in Psychosis and Markers of Treatment-Resistant Schizophrenia

Large-scale analysis of DNA methylation identifies cellular alterations in blood from psychosis patients and molecular biomarkers of treatment-resistant schizophrenia

Linkage disequilibrium mapping of chromosome 22 in schizophrenia using DNA pooling on Chinese and Scottish populations

Identification of Schizophrenia-Associated Loci by Combining DNA Methylation and Gene Expression Data from Whole Blood

Genome-wide analysis of DNA methylation in 106 schizophrenia family trios in Han Chinese

Genome-wide DNA Methylation Analysis in Families with Multiple Individuals Diagnosed with Schizophrenia and Intellectual Disability.

Schizophrenia is associated with altered DNA methylation variance

Altered DNA methylation of the Alu Y subfamily in schizophrenia and bipolar disorder

An integrated genetic-epigenetic analysis of schizophrenia: evidence for co-localization of genetic associations and differential DNA methylation

Allele-specific DNA methylation maps in monozygotic twins discordant for psychiatric disorders reveal that disease-associated switching at the EIPR1 regulatory loci modulates neural function

Genome-wide DNA methylation analysis of peripheral blood cells derived from patients with first-episode schizophrenia in the Chinese Han population

Investigating the relationship between DNA methylation, genetic variation, and suicide attempt in bipolar disorder

Recombination Suppression in the Vicinity of the Breakpoints of a Balanced 1:11 Autosomal Translocation Associated with Schizophrenia and Other Forms of Major Mental Illness

Integrating brain methylome with GWAS for psychiatric risk gene discovery

Methylation Patterns in Whole Blood Correlate with Symptoms in Schizophrenia Patients.

Genome-wide DNA methylation analysis of human brain tissue from schizophrenia patients

Psychotic symptoms associated increased CpG methylation of metabotropic glutamate receptor 8 gene in Chinese Han males with schizophrenia and methamphetamine induced psychotic disorder: a longitudinal study

CHARACTERIZATION OF CROSS-TISSUE Mqtl EFFECTS AND THEIR RELEVANCE IN PSYCHIATRIC DISORDERS

Enrichment of Cis -Regulatory Gene Expression SNPs and Methylation Quantitative Trait Loci among Bipolar Disorder Susceptibility Variants